Search

everythinglearnresearchcommunity

for

Search:↓

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Laminin-511 may help promote hair growth, while laminin-332 does not affect hair loss.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Intu gene is crucial for hair follicle formation by helping keratinocytes differentiate through primary cilia.

Certain drugs that block specific enzymes can help treat prostate diseases.

Upadacitinib improved multiple immune-related conditions in one patient.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Applying InlB321/15 to wounds sped up healing in mice.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

New compounds show promise as nonsteroidal treatments for hair loss.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.